SCHEMBL2125103

SCHEMBL2125103

CCCCCCc1ccccc1C(C)=O

nearest known ligand 0.56

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
LIPG Q9Y5X9 1/20 0.56
BID P55957 3/20 0.51
MCL1 Q07820 3/20 0.51
PPARA Q07869 3/20 0.51
BCL2L1 Q07817 2/20 0.51
BAK1 Q16611 2/20 0.51
KAT8 Q9H7Z6 2/20 0.51
PPARG P37231 2/20 0.51
EP300 Q09472 1/20 0.51
KAT2A Q92830 1/20 0.51
KAT2B Q92831 1/20 0.51
KAT5 Q92993 1/20 0.51
SAE1 Q9UBE0 1/20 0.51
THRA P10827 1/20 0.50
THRB P10828 1/20 0.50
CYSLTR2 Q9NS75 6/20 0.49
CYSLTR1 Q9Y271 6/20 0.49
TSHR P16473 1/20 0.49
ALDH1A1 P00352 1/20 0.49
LMNA P02545 1/20 0.49

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5164407 1.00 LIPG (0.56) LIPGBIDMCL1PPARABCL2L1
SCHEMBL11422882 1.00 LIPG (0.56) LIPGBIDMCL1PPARABCL2L1
SCHEMBL5709997 1.00 LIPG (0.56) LIPGBIDMCL1PPARABCL2L1
SCHEMBL1577630 1.00 LIPG (0.56) LIPGBIDMCL1PPARABCL2L1
SCHEMBL11441324 1.00 LIPG (0.56) LIPGBIDMCL1PPARABCL2L1
SCHEMBL2123855 1.00 LIPG (0.56) LIPGBIDMCL1PPARABCL2L1
SCHEMBL298005 0.98 LIPG (0.53) LIPGBIDMCL1PPARABCL2L1
SCHEMBL1131361 0.93 TSHR (0.46) LIPGBIDMCL1PPARABCL2L1
SCHEMBL7649273 0.87 LIPG (0.58) LIPGBIDMCL1PPARABCL2L1
SCHEMBL2970919 0.87 LIPG (0.58) LIPGBIDMCL1PPARABCL2L1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 14 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2026102164-A1 COMPOSITIONS AND METHODS OF USE THEREOF BOARD OF SUPERVISORS OF LOUISIANA STATE UNIVERSITY AND AGRICULTURAL AND MECHANICAL COLLEGE (US) 2026-05-15 WO disclosed
EP-2970677-A2 SMALL SCALE MICROENCAPSULATED PIGMENTS AND USES THEREOF Chromatic Technologies, Inc. (US) 2016-01-20 EP disclosed
EP-2809733-A1 THERMOCHROMIC SYSTEMS WITH CONTROLLED HYSTERESIS Chromatic Technologies, Inc. (US) 2014-12-10 EP disclosed
WO-2014144853-A2 SMALL SCALE MICROENCAPSULATED PIGMENTS AND USES THEREOF CHROMATIC TECHNOLOGIES INC. (US) 2014-09-18 WO disclosed
US-8716531-B2 Method for producing norbornene derivative JX NIPPON OIL & ENERGY CORPORATION (JP) 2014-05-06 US disclosed
WO-2013115800-A1 THERMOCHROMIC SYSTEMS WITH CONTROLLED HYSTERESIS CHROMATIC TECHNOLOGIES, INC. (US) 2013-08-08 WO disclosed
US-20120108851-A1 METHOD FOR PRODUCING NORBORNENE DERIVATIVE JX NIPPON OIL & ENERGY CORPORATION (JP) 2012-05-03 US disclosed
EP-2444386-A1 PROCESS FOR PREPARATION OF NORBORNENE DERIVATIVES JX Nippon Oil & Energy Corporation (JP) 2012-04-25 EP disclosed
EP-2247673-A1 REVERSIBLE THERMAL DISCOLORATION AQUEOUS INK COMPOSITION AND WRITING IMPLEMENT USING THE SAME AND WRITING IMPLEMENT SET THE PILOT INK CO., LTD. (JP) 2010-11-10 EP disclosed
WO-2009107855-A1 REVERSIBLE THERMAL DISCOLORATION AQUEOUS INK COMPOSITION AND WRITING IMPLEMENT USING THE SAME AND WRITING IMPLEMENT SET THE PILOT INK CO., LTD. (JP) 2009-09-03 WO disclosed
EP-0985649-B1 Method for producing an aromatic compound having an alkyl group with at least three carbon atoms TORAY INDUSTRIES (JP) 2004-11-24 EP disclosed
US-6462248-B1 THROUGH CONVERSION, ISOMERIZATION AND/OR ADSORPTIVE SEPARATION OF AROMATIC COMPOUNDS TORAY INDUSTRIES, INC. (JP) 2002-10-08 US disclosed
WO-2000075094-A2 METHOD FOR PRODUCING A HALOGENATED ACETOPHENONE ISHIHARA SANGYO KAISHA, LTD. (JP) 2000-12-14 WO disclosed
EP-0985649-A2 Method for producing an aromatic compound having an alkyl group with at least three carbon atoms TORAY INDUSTRIES, INC. (JP) 2000-03-15 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120108851-A1 METHOD FOR PRODUCING NORBORNENE DERIVATIVE UGT1A8, UGT8, ALG8 LIPG 4338/4885BID 4824/4885MCL1 1341/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.